Literature DB >> 32222308

Cognitive Impairment and Dementia in Parkinson Disease.

Jennifer G Goldman1, Erica Sieg2.   

Abstract

In the comprehensive care of people with Parkinson disease (PD), recognition of cognitive impairment is essential. Cognitive impairment in PD can be varied in its clinical features and rates of progression and is now recognized to occur throughout the disease, from early, de novo to more advanced stages. However, the many factors related to the disease itself, underlying pathologies, comorbidities, and genetics may play a role in the development of mild cognitive impairment (PD-MCI) and dementia (PDD). To date, the field lacks curative or disease-modifying treatments for PD cognitive impairment and has few effective, robust symptomatic therapies for PDD or PD-MCI.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Dementia; Diagnostic criteria; Executive function; Memory; Mild cognitive impairment; Neuropsychological assessment

Mesh:

Year:  2020        PMID: 32222308     DOI: 10.1016/j.cger.2020.01.001

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  14 in total

Review 1.  Frailty and cognitive impairment in Parkinson's disease: a systematic review.

Authors:  M C Sousa-Fraguas; G Rodríguez-Fuentes; N M Conejo
Journal:  Neurol Sci       Date:  2022-09-02       Impact factor: 3.830

2.  Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.

Authors:  Kyum-Yil Kwon; Suyeon Park; Rae On Kim; Eun Ji Lee; Mina Lee
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

Review 3.  Neuromodulation of cognition in Parkinson's disease.

Authors:  Rachel C Cole; Derrick N Okine; Brooke E Yeager; Nandakumar S Narayanan
Journal:  Prog Brain Res       Date:  2022-02-11       Impact factor: 2.624

4.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

5.  Effect of Acupuncture on Cognitive Function of Insomnia Patients Compared with Drugs: A Protocol for Meta-analysis and Systematic Review.

Authors:  Shan Qin; Jing Jiang; Wen-Zhong Wu; Xiao-Qiu Wang; Han-Qing Xi; Qin-Qin Fang; Bin Xu; Cheng-Yong Liu
Journal:  Behav Neurol       Date:  2021-09-11       Impact factor: 3.342

6.  A Longitudinal Randomized Controlled Trial Protocol to Evaluate the Effects of Wuqinxi on Dynamic Functional Connectivity in Parkinson's Disease Patients.

Authors:  Yuting Li; Lanlan Zhang; Yin Wu; Jian Zhang; Ke Liu
Journal:  Front Hum Neurosci       Date:  2021-09-10       Impact factor: 3.169

Review 7.  Frameworks for Parkinson's Disease Rehabilitation Addressing When, What, and How.

Authors:  Miriam R Rafferty; Ella Nettnin; Jennifer G Goldman; Jillian MacDonald
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-22       Impact factor: 5.081

8.  Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease.

Authors:  Brenna A Cholerton; Kathleen L Poston; Laurice Yang; Liana S Rosenthal; Ted M Dawson; Alexander Pantelyat; Karen L Edwards; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Thomas J Montine; Cyrus P Zabetian
Journal:  J Clin Exp Neuropsychol       Date:  2021-08-06       Impact factor: 2.283

Review 9.  Approach to Cognitive Impairment in Parkinson's Disease.

Authors:  Qiang Zhang; Georgina M Aldridge; Nandakumar S Narayanan; Steven W Anderson; Ergun Y Uc
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 6.088

Review 10.  Lewy Body Dementias: A Coin with Two Sides?

Authors:  Ángela Milán-Tomás; Marta Fernández-Matarrubia; María Cruz Rodríguez-Oroz
Journal:  Behav Sci (Basel)       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.